|Year : 2018 | Volume
| Issue : 1 | Page : 77-80
One-year review of pityriasis rosea among outpatients in Kano, Northwestern Nigeria
SM Yusuf, UA Tijjani, I Nashabaru, H Saidu, ID Gezawa, MS Mijinyawa
Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria
|Date of Web Publication||23-Mar-2018|
Dr. M S Mijinyawa
Department of Medicine, Aminu Kano Teaching Hospital, Kano
Source of Support: None, Conflict of Interest: None
Background: Pityriasis rosea (PR) is an acute self-limiting papulo-squamous skin disorder commonly observed in otherwise healthy children and young adults. Objective: To describe the clinical pattern of PR in Kano, Northwest Nigeria. Materials and Methods: This was a descriptive cross-sectional study that was carried out between June 2010 and May 2011 among out-patients attending three dermatology clinics in Kano, Nigeria. Patients with rashes that met the clinical diagnostic criteria of PR were recruited and followed up until there was resolution of lesions. The demographic characteristics of the patients were recorded along with the clinical manifestations of the lesions. All the data obtained were analysed using SPSS for Windows. Results: Out of 1,528 patients seen over the 12 months study period, 56 patients had PR out of which 23 (41.1%) were males and 33 (58.9%) were females, giving a male:female ratio of 1:1.4. PR, therefore, accounted for 3.6% of all dermatology out-patient visits in Kano. The patients' ages ranged from 6 years to 55 years with most of them in the age range of 11–20 years. The peak month of incidence was January in which about a quarter (21%) of the patients were seen. Only 5 (8.9%) patients had prodromal symptoms preceding the onset of the rash. Herald patch, which was mainly located on the trunk, was present in 45 (80%) of the studied patients. Secondary eruptions appeared within 7 days after the herald patch in 69% and had a typical Christmas tree pattern of distribution along the line of skin cleavage in 70% of the patients. Approximately three-quarter (73 %) of the patients had complete resolution of the rash by the 4th week. Recurrence was not reported 24 weeks after the last patient was seen. Conclusion: The pattern of presentation of PR was not different from that observed by other researchers. However, contrary to earlier reports from south Nigeria, our study shows that PR occurs more frequently during the cold dry season.
Keywords: Herald patch, incidence, Kano, pityriasis rosea, season
|How to cite this article:|
Yusuf S M, Tijjani U A, Nashabaru I, Saidu H, Gezawa I D, Mijinyawa M S. One-year review of pityriasis rosea among outpatients in Kano, Northwestern Nigeria. Niger J Basic Clin Sci 2018;15:77-80
|How to cite this URL:|
Yusuf S M, Tijjani U A, Nashabaru I, Saidu H, Gezawa I D, Mijinyawa M S. One-year review of pityriasis rosea among outpatients in Kano, Northwestern Nigeria. Niger J Basic Clin Sci [serial online] 2018 [cited 2021 Jun 23];15:77-80. Available from: https://www.njbcs.net/text.asp?2018/15/1/77/228350
| Introduction|| |
Pityriasis rosea (PR) is an acute self-limiting papulo-squamous skin disorder commonly observed in otherwise healthy children and young adults, though it may develop at any age., The disease has a worldwide distribution with a global incidence of approximately 2% of out-patient dermatologic visits. Both sexes seem to be equally affected, though a female preponderance has been observed in a few studies. The disease is widely reported to exhibit seasonal variation with more cases occurring during spring and fall in temperate regions., Reports from Africa, however, show variable seasonal relationship. PR has variable morphological patterns and disease course in different geographical regions. Therefore, we set out to describe the pattern of the disease encountered in out-patients attending dermatology clinics in Kano, Nigeria.
| Materials and Methods|| |
This was a prospective observational study carried out in three out-patient dermatology clinics in Kano, Nigeria (Aminu Kano Teaching Hospital, Kano; Mohammed Abdullahi Wase Specialist Hospital, Kano and General Hospital, Yadakunya, Kano) between June 2010 and May 2011. The study commenced after obtaining clearance from the Health Research Ethics Committee. All new patients seen at these clinics were registered and clinically evaluated. Those who satisfied the inclusion criteria for the study were recruited.
For this study, clinical diagnosis of PR was made if 3 of the following 4 clinical features were observed: (1) herald patch, (2) peripheral collarette scaling, (3) mainly truncal and proximal limb distribution and (4) orientation of lesions along lines of skin cleavage, parallel to the ribs, or in a Christmas tree or anti-Christmas tree pattern. These diagnostic criteria were validated and applied in other studies.,, Detailed history was obtained and examination of the rashes was carried out on each respondent using an interviewer administered questionnaire.
Investigations including skin biopsy, Venereal disease research laboratory (VDRL) and fungal studies were done, especially in doubtful cases to further exclude other diseases that may have similar presentation.
The patients were then followed up at regular intervals and at each visit changes were recorded until complete resolution of the lesion occurred. The data obtained were analysed using SPSS for Windows (version 13.0; SPSS Inc. Chicago, Illinois, USA) statistical software package. Continuous variables were expressed as mean (SD), whereas categorical variables were expressed as proportions. Student's t-test was used to compare differences between quantitative variables, whereas chi-square test was used to compare qualitative variables. Statistical significance was set at P< 0.05.
| Results|| |
A total of 1,528 new patients were seen in the three out-patient dermatology clinics over the period of study (June 2010 to May 2011). Of these, 56 patients satisfied the inclusion criteria and were recruited for the study, yielding an incidence of 3.6%. Of the 56 patients with PR, 23 were males and 33 were females giving a male-female ratio of 1:1.4. The youngest patient in the study was 6 years old whereas the oldest was 55 years old with a mean age of 18.1 ± 12.27 years. The highest incidence of PR was observed in the age group 11–20 years [Table 1].
The peak month of incidence was January as depicted in [Figure 1], during which about one-quarter (21%) of the patients were seen. Prodromal symptoms preceding the onset of the rash were reported by 5 (9.8%) patients.
Presence of herald patch was observed in 45 (80%) of the patients studied. Of them, 42 (93%) had only one herald patch, whereas the remaining 3 (7%) had two or more herald patches. The clinical characteristics of the patients with PR are given in [Table 2]. Herald patch was located on the trunk in 32 (72%) patients. It occurred on the upper limbs in 10 (22 %), the lower limbs in 2 (4%) and the neck in 1 (2%) patients. The interval between the herald patch and the appearance of secondary eruptions was within 7 days in 38/56 (69%) of the patients, but by the 14th day, 54/56 (97%) of the patient had developed an eruption. The distribution of secondary eruptions was mainly the trunk, followed by the trunk and extremities. Six (10%) patients had facial involvement. The classic pattern with the rash in the typical Christmas tree pattern along the line of skin cleavage was seen in 39/56 (70%) of our patients. Atypical forms were encountered in relatively small proportions. Localised PR was observed in 6 (9%) patients, inverse in 10 (18%) and unilateral in only 1 patient.
The plaques type was the most common morphology of the secondary rashes, which occurred in 33 (59%) of the patients. This was followed by the papular variant that was seen in 22 (39%) patients, whereas the urticarial type was seen in 1 (2%) patient [Table 2].
History of contact with anyone with similar rashes was obtained in only 4% and history of similar rashes was obtained in 9% of the patients.
Fifteen percent of the patients had complete resolution of the rash within 2 weeks. By the 4th week, 73% of the patients had complete resolution. Only 6 patients (13%) had rashes extending up to and beyond 12 weeks. Recurrence was not reported 24 weeks after the last patient was seen.
Other significant changes observed were post-inflammatory pigmentary changes, with hyperpigmentation (PIH) being more common, which was observed in 4 (7%) patients at 4th week follow-up. Post-inflammatory hypopigmentation was seen in only 1 patient by the 8th week follow-up. Secondary bacterial infection of the lesions was not observed. None of the cases studied was positive for VDRL, whereas only one case of HIV was encountered. The patient was diagnosed with the HIV about 3 years earlier and was on HAART (highly active anti-retroviral treatment). Only 40% of the patients with PR had lymphocytosis, whereas 22% had elevated ESR.
| Discussion|| |
The incidence of PR in the present study was 3.7%, which falls within the range obtained from similar studies from different regions of Nigeria. These studies reported a range of incidence from 2.4 to 3.7 per 100 dermatological patients. In various studies, PR has been reported to be equally common in both sexes. The slight female preponderance obtained from this study was also reported by earlier study in Nigeria., A few other studies have also shown female preponderance., These observations could possibly have been caused by greater cosmetic concern in women. There is likely no real sex predisposition as reported in some studies.
Previous studies have reported contradicting results for seasonal variation of PR. Studies in the UK, USA  and Sudan  reported higher incidence of PR in the colder months. One study from southern Nigeria  reported higher incidence in the early part of the rainy season. A study in Brazil  and another in Singapore  reported a bimodal distribution. No seasonal variation was reported by studies from Turkey  and Singapore. The present study showed the highest incidences of PR occurring from the month of November -to January, which coincided with the onset of dusty, cold dry season. Our finding is, thus, in agreement with those reporting that most cases occurring in winter.
Prodromal illness such as upper respiratory tract infection (cough/catarrh) was seen in 5 (9.8%) patients; this rate was similar to what was reported by other researchers.,,
In this study, herald patch was reported in 45 (80%) patients, with the most common location being the trunk. This was seen in 32 (71.1%) patients. These findings were similar to what was reported previously, where the occurrence of herald patch was seen in 40–76%,, with the most common reported site being the trunk in 48.7–57.2.,,
The classical PR constituted 70% (39/56) of the studied cases, which is in tandem with other studies that reported herald patch in 80%. Atypical PR was seen in 17 (30%) patients; inverse PR was found in 10 (18%) patients, localised PR in 6 (10%) patients and unilateral in 1 (2%) patient. These values are similar but slightly higher than that in other studies.,, Tay et al. reported inverse PR of 6% in their studied patients, while localised PR was present in 4% in a study by Egwin. Our findings support an earlier study that showed inverse distribution of PR is more frequent in black patients.
Findings from this study showed that secondary eruptions occurred within the first 2 weeks of the appearance of the HP in 97%, which is in disagreement with the study of Sharma et al. who reported that secondary eruptions occurred within 10 days after HP in 62.5% of the patients.
Secondary eruptions were most commonly distributed on the trunk in 94%, which is similar to previous studies.,
The secondary lesions may be papules, vesicles, pustules or urticarial or purpuric plaques. The plaque type was the dominant morphological variant seen in our study, which occurred in 59% of the cases. This finding was similar to what Bernardin et al. found in their study. Papular PR was seen in 39% of the cases. This corroborates with the findings in black Americans where the papular and vesicular varieties accounted for approximately 35% of their cases.
Oral mucosal involvement was reported to vary in frequency from 1% to 16%.,
In comparison, none of our study patients presented with mucosal involvement. PR may be asymptomatic or it may present with pruritus. This symptom is mild in 25% of the cases, mild to moderate in 50%, and severe in 25% itching., Itching was the predominant symptom reported in this study as it was reported in 53 (84%) patients. This finding is similar to what was reported by Egwin et al. in India.
Only a few patients reported detecting aggravating or relieving factors for their disease, most of which was the worsening of the rashes after taking ampicillin either taken on self-medication or prescribed by the general practitioner (GP). A similar observation was made by earlier studies in Nigeria.,
PR is a self-limiting disorder that spontaneously remit within 6 to 8 weeks.,,, In our study, 73% of our patients had complete resolution of the rash by the 4th week and 15% had resolution of the rash within 2 weeks. Only 6 patients (13%) had rashes extending up to 12 weeks and beyond.
| Conclusion|| |
The pattern of presentation of PR was not different from what was observed by other researchers. However, contrary to earlier reports from the southern part of Nigeria, our study shows that PR occurs more frequently during the cold dry season.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Browning JC. An update on pityriasis rosea and other similar childhood exanthems. Current Opin Pediatr 2009;21:481-5.
Vigh G. Observations on pityriasis rosea patients. Z Hauktr 1983;58:1268-72.
González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: An important papulosquamous disorder. Int J Dermatol 2005;44:757-64.
Sharma L, Srivastava K. Clinicoepidemiological study of pityriasis rosea. Indian J Dermatol Venereol Leprol 2008;74:647-9.
] [Full text]
Chuh AA, Molinari N, Sciallis G, Harman M, Akdeniz S, Nanda A. Temporal case clustering in pityriasis rosea: A regression analysis in 1379 patients in Minnesota, Kuwait and Diyarbakir, Turkey. Arch Dermatol 2005;141:767-71.
Traore AKursaga-Some NNiamba PBarro FSanou IDrabo YJ. Pityriasis rosea in secondary schools in Ouagadougou, Burkina Faso. Ann Dermatol Venereol 2001;128:605-9.
Chuh AA. Diagnostic criteria for Pityriasis rosea: A prospective case control study for assessment of validity. J Eur Acad Dermatol Venereol 2003;17:101-3.
Chuh AA, Chiu SS, Peiris JS. Human herpes virus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with Pityriasis rosea by polymerase chain reaction: A prospective case control study. Acta Derm Venereol 2001;81:289-90.
Chuh AA, Chan HH. Prospective case-control study of chlamydia, legionella and mycoplasma infections in patients with Pityriasis rosea. Eur J Dermatol 2002;12:170-3.
Jacyk WK. Pityriasisrosea in Nigerians. Int J Dermatol 1980;19:397-9.
Ayanlowo O, Akinkugbe A, Olumide Y. The Pityriasis rosea calendar: A seven year review of seasonal variation, age and sex distribution. Nig Q Hosp Med 2010;1:29-31.
Olumide Y. Pityriasis rosea in Lagos. Int J Dermatol 1987;26:234-6.
Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982;7:80-9.
Harman M, Iytekin S, Ackdeniz S, Inaloz HS. An epidemiological study of pityriasis rosea inthe Eastern Anatolia. Eur J Epdemiol.1999:14;4952-497
Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: How correct is the classic description? Arch Pediatr Adolesc Med 2007;11:503-6.
Messenger AG, Knox EG, Summerly R, Muston HL, Ilderton E. Case clustering in pityriasisrosea: Support for role of an infective agent. Br Med J (Clin Res Ed) 1982;284:371-3.
Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasisrosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982;7:80-9.
Ahmed MA. Pityriasisrosea in the Sudan. Int J Dermatol 1986;25:184-5.
de Souza Sittart JA, Tayah M, Soares Z. Incidence Pityriasis rosea of Gibert in the Dermatology Service of the Hospital do Servidor Publico in the state of São Paulo [in Portuguese]. Med Cutan Ibero Lat Am 1984;12:336-8.
Cheong WK, Wong KS. An epidemiological study of Pityriasis rosea in Middle Road Hospital. Singapore Med J 1989;30:60-2.
Tay YK, Goh CL. One-year review of Pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore 1999;28:829-31.
Chuh AA. Pityriasis rosea-Evidence for and against an infectious aetiology. Epidemiol Infect 2004;132:381-90.
Chuang T, Perry HO, Ilstrup DM, Kurland LT. Recent upper respiratory tract infection and pityriasis rosea: A case control study of 249 matched pairs. Br J Dermatol 1983;108:587-91.
Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: Review of the literature and experience of an Italian drug surveillance centre. Dermatol Online J 2006;12:1.
Chuh AA, Lee A, Zawar V, Sciallis G, Kempf W. Pityriasis rosea - An update. Indian J Dermatol Venereol Leprol 2005;71:311-5.
] [Full text]
Ganguly S. A clinicoepidemiological study of pityriasis rosea in South India. Skinmed. 2013;11:141-6.
Bernardin RM. Ritter SE. Murchland MR. Papular pityriasis rosea. Cutis 2002;70:51-5.
Deng Y, Li H, Chen X. Palmoplantar pityriasis rosea: Two case reports. J Eur Acad Dermatol Venereol 2007;21:406-7.
Sharma L, Srivastava K. Clinicoepidemiological study of pityriasisrosea. Indian J Dermatol Venereol Leprol 2008;74:647-9.
] [Full text]
Dashore A, Jain VK, Chaudhry SD. Oral lesions in pityriasis rosea. Indian J Dermatol Venereol Leprol 1988;54:140-1.
] [Full text]
Vidimos AT, Camisa C. Tongue and cheek: Oral lesions in pityriasis rosea. Cutis 1992;50:276-80.
[Table 1], [Table 2]